We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSHA icon
4226
Taysha Gene Therapies
TSHA
$1.92B
$13K ﹤0.01%
626
+333
+114% +$9.02K
ULH icon
4227
Universal Logistics Holdings
ULH
$518M
$13K ﹤0.01%
510
-1,425
-74% -$34.2K
VLUE icon
4228
iShares MSCI USA Value Factor ETF
VLUE
$9.72B
$13K ﹤0.01%
+129
New +$12.4K
VXX icon
4229
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
$13K ﹤0.01%
17
-1,694
-99% -$1.69M
CTR
4230
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$13K ﹤0.01%
656
-138
-17% -$2.51K
EXPR
4231
DELISTED
Express, Inc.
EXPR
$13K ﹤0.01%
164
-2,053
-93% -$129K
CDAK
4232
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$13K ﹤0.01%
872
+339
+64% +$7.37K
PHAS
4233
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$13K ﹤0.01%
3,696
-6,190
-63% -$25.1K
LEAP
4234
DELISTED
Ribbit LEAP, Ltd.
LEAP
$13K ﹤0.01%
1,186
+1,086
+1,086% +$14.6K
MILE
4235
DELISTED
Metromile, Inc. Common Stock
MILE
$13K ﹤0.01%
+1,298
New +$19.8K
SREV
4236
DELISTED
ServiceSource International, Inc.
SREV
$13K ﹤0.01%
8,830
-17,495
-66% -$28.9K
SEAH.U
4237
DELISTED
Sports Entertainment Acquisition Corp. Units, each consisting of one share of Class A Common Stock,
SEAH.U
$13K ﹤0.01%
1,256
-274
-18% -$3.01K
VEI
4238
DELISTED
Vine Energy Inc.
VEI
$13K ﹤0.01%
+980
New +$13.7K
MDLA
4239
DELISTED
Medallia, Inc.
MDLA
$13K ﹤0.01%
469
-2,187
-82% -$81.2K
GFN
4240
DELISTED
General Finance Corporation
GFN
$13K ﹤0.01%
1,070
-4,029
-79% -$40.8K
RYM
4241
RYTHM Inc
RYM
$48.4M
0
ALTG icon
4242
Alta Equipment Group
ALTG
$234M
$12K ﹤0.01%
890
-3,699
-81% -$40.3K
ASYS icon
4243
Amtech Systems
ASYS
$280M
$12K ﹤0.01%
987
-146
-13% -$1.35K
BBU
4244
DELISTED
Brookfield Business Partners
BBU
$12K ﹤0.01%
467
-141
-23% -$3.59K
BDSX icon
4245
Biodesix
BDSX
$251M
$12K ﹤0.01%
29
+8
+38% +$3.57K
BRID icon
4246
Bridgford Foods
BRID
$55.9M
$12K ﹤0.01%
761
-87
-10% -$1.41K
CGBD icon
4247
Carlyle Secured Lending
CGBD
$782M
$12K ﹤0.01%
964
-348
-27% -$4.21K
CHMG icon
4248
Chemung Financial Corp
CHMG
$403M
$12K ﹤0.01%
286
-959
-77% -$35.9K
CWCO icon
4249
Consolidated Water Co
CWCO
$502M
$12K ﹤0.01%
884
-3,144
-78% -$41.9K
DSGN icon
4250
Design Therapeutics
DSGN
$901M
$12K ﹤0.01%
+398
New +$13.4K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.